Garri Zmudze Insights

CONTRIBUTED CONTENT

Garri contributes op-eds and original content for leading outlets across web3, health, startups, and more.

AgeTech World: Longevity Will Never Be a Magic Pill That Will Make Us Younger

I share my drive and LongeVC's strategic investments in advancing an ageless future, emphasising the need for standardised longevity practises and systemic health economics reform
Contributed Content
·
3 min
·
November 7, 2023
AgeTech World: Longevity Will Never Be a Magic Pill That Will Make Us Younger

Clinical Leader: Future Funding, Trial Success Necessitates Use Of AI

AI is markedly transforming clinical trials, from enhancing predictive capabilities and patient adherence insights to optimizing trial design and expediting drug development.
Contributed Content
·
1 min
·
October 16, 2023
Clinical Leader: Future Funding, Trial Success Necessitates Use Of AI

Clinical Leader: Decentralization, it's more than you think

Decentralization encourages transparency, inclusion, and new funding streams for clinical research.
Contributed Content
·
3 min
·
August 2, 2023
Clinical Leader: Decentralization, it's more than you think

EXPERT COMMENTARY

Garri is a leading voice for trending topics in the field of health and investing.

LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

LongeVC invests in Interface Biosciences, securing $3 million for pioneering pharmaceutical development from bacterial natural products, marking a strategic advancement towards critical IND-enabling studies
Expert Commentary
·
5 min
·
Jul 27
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

BioSpectrum: Seeking the 'fountain of youth'

Garri founded the Longevity Science Foundation to fund the diverse treatments contributing to human longevity.
Expert Commentary
·
4 min
·
Jul 27
BioSpectrum: Seeking the 'fountain of youth'

Sifted: Purrsonalised health: The startups and VCs betting on pet genetics

Animal genetics market revenue is predicted to exceed $6.4bn by 2027. Here are some of the pet genetics startups to watch.
Expert Commentary
·
1 min
·
Jul 27
Sifted: Purrsonalised health: The startups and VCs betting on pet genetics

ANNOUNCEMENT

Stay up-to-date with the latest from Garri and the companies within his realm.

Forbes: Meet a VC on a mission to support women in longevity

Garri leads LongeVC to invest in diverse founders that will ensure a representative future of longevity and biotech.
Announcements
·
2 min
·
Jul 27
Forbes: Meet a VC on a mission to support women in longevity

LongeVC Supports UNP's $32M Series A Funding for AI-Driven Macrocycle Drug Development

LongeVC Partakes in UNP's $32 Million Series A Funding, Boosting AI-Driven Macrocycle Innovation for Oncology and Beyond
Announcements
·
2 min
·
Jul 27
LongeVC Supports UNP's $32M Series A Funding for AI-Driven Macrocycle Drug Development

Garri Zmudze Speaking at The Asia Summit on Global Health (ASGH) in Hong Kong

Garri Zmudze will attend this year’s Asia Summit on Global Health (ASGH 2024) as a speaker and investor. He will participate in the "New Frontiers in Healthy Ageing" panel.
Announcements
·
4 min
·
Jul 27
Garri Zmudze Speaking at The Asia Summit on Global Health (ASGH) in Hong Kong

ALL RESOURCES

Content at the cutting-edge of health and technology.

Longevity.Technology: The time is right for specialist Longevity investment

Garri Zmudze, Sergey Jakimov, and Ilya Suharenko launch a new fund for longevity research: LongeVC.
Announcements
·
2 min
·
Jul 27
Longevity.Technology: The time is right for specialist Longevity investment

Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health

Garri was an angel investor in pet health company Basepaws. Its acquisition offers promising insights into the future of human longevity.
Announcements
·
7 min
·
Jul 27
Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health

ARDD: Decentralized science and blockchain in aging research

Garri explains the Longevity Science Foundation's work as a nonprofit supporting a decentralized and transparent future of longevity research.
Announcements
·
4 min
·
Jul 27
ARDD: Decentralized science and blockchain in aging research

Forbes: Meet a VC on a mission to support women in longevity

Garri leads LongeVC to invest in diverse founders that will ensure a representative future of longevity and biotech.
Announcements
·
2 min
·
Jul 27
Forbes: Meet a VC on a mission to support women in longevity

LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

LongeVC invests in Interface Biosciences, securing $3 million for pioneering pharmaceutical development from bacterial natural products, marking a strategic advancement towards critical IND-enabling studies
Expert Commentary
·
5 min
·
Jul 27
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform

LongeVC Supports UNP's $32M Series A Funding for AI-Driven Macrocycle Drug Development

LongeVC Partakes in UNP's $32 Million Series A Funding, Boosting AI-Driven Macrocycle Innovation for Oncology and Beyond
Announcements
·
2 min
·
Jul 27
LongeVC Supports UNP's $32M Series A Funding for AI-Driven Macrocycle Drug Development

Garri Zmudze Speaking at The Asia Summit on Global Health (ASGH) in Hong Kong

Garri Zmudze will attend this year’s Asia Summit on Global Health (ASGH 2024) as a speaker and investor. He will participate in the "New Frontiers in Healthy Ageing" panel.
Announcements
·
4 min
·
Jul 27
Garri Zmudze Speaking at The Asia Summit on Global Health (ASGH) in Hong Kong

Summary of LongeVC’s Investments in Q1 and Q2

As we’re getting to the end of Q2, we prepared a quick summary of all the new additions to LongeVC’s investment portfolio.
Announcements
·
3 min
·
Jul 27
Summary of LongeVC’s Investments in Q1 and Q2

LongeVC’s Q3 & Q4 2024: Investments and Portfolio Updates

LongeVC shares Q3 & Q4 2024 updates, including new investments in Glyphic Bio and Proton Intelligence, as well as key portfolio developments from Turn Bio and Longenesis.
Announcements
·
5 min
·
Jul 27
LongeVC’s Q3 & Q4 2024: Investments and Portfolio Updates

BioSpectrum: Seeking the 'fountain of youth'

Garri founded the Longevity Science Foundation to fund the diverse treatments contributing to human longevity.
Expert Commentary
·
4 min
·
Jul 27
BioSpectrum: Seeking the 'fountain of youth'
© 2024